Advertisement
Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

For patients with diabetes mellitus undergoing percutaneous coronary intervention

High Lipoprotein(a) Predicts Cardiac Events in DM With PCI

0
High Lp(a) independent predictor of cardiac death, acute coronary syndrome in multivariate analysis
For women with diabetes who are using hormonal contraception

Low Thromboembolism Risk for Contraceptive Use in Diabetes

0
Among women with diabetes, lowest rates seen with use of intrauterine and subdermal contraceptives
Variants in genes encoding proprotein convertase subtilisin-kexin type 9 and 3-hydroxy-3-methylglutarylcoenzyme A reductase are associated with almost equivalent effects on the risk of cardiovascular events and diabetes per unit decrease in low-density lipoprotein cholesterol level

Similar Effects for PCSK9, HMGCR Variant-Mediated Lower LDL

0
Almost equivalent effects on cardiovascular events, diabetes per unit decrease in LDL-cholesterol level

November 2016 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2016. This roundup includes...
In early November

As Prices Soar, ADA Calls for Access to Affordable Insulin

0
American Diabetes Association asks Congress to investigate the matter
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events

GI Adverse Events Up With GLP-1 Receptor Agonists

0
Risk varies based on dose, background medications, and type of GLP-1 RA
A new implantable continuous glucose monitoring system seems to be safe and accurate for diabetes

Implantable Continuous Glucose Monitoring System Safe, Accurate

0
>99 percent of samples in clinically acceptable error zones A and B in Clarke Error Grid Analysis
For patients with diabetes mellitus

Deferred Revascularization Tied to Poor Outcomes in Diabetes

0
Previous MI is effect modifier for patients with FFR-negative medically treated lesions
Medicare Part D has effectively reduced the out-of-pocket cost burden of prescription drugs for beneficiaries with diabetes

Part D Has Reduced Out-of-Pocket Rx Drug Costs in Diabetes

0
Decrease in proportion of Part D beneficiaries who experienced coverage gap to 40.9 percent in 2011

October 2016 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2016. This roundup includes...